May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Complement Factor H, LOC387715 and Age-Related Macular Degeneration: Population-Based Case Control Study
W. T. Smith; J. J. Wang; G. Burlutsky; C.-C. Chan; S. K. Iyengar; J. Tuo; C. Xing; P. Mitchell; Blue Mountains Eye Study
Author Affiliations & Notes
  • W. T. Smith
    Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Australia, New Lambton, Australia
  • J. J. Wang
    Ophthalmology (Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital), University of Sydney, Sydney, Australia
  • G. Burlutsky
    Ophthalmology (Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital), University of Sydney, Sydney, Australia
  • C.-C. Chan
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • S. K. Iyengar
    Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • J. Tuo
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • C. Xing
    Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio
  • P. Mitchell
    Ophthalmology (Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital), University of Sydney, Sydney, Australia
  • Blue Mountains Eye Study
    Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Australia, New Lambton, Australia
  • Footnotes
    Commercial Relationships W.T. Smith, None; J.J. Wang, None; G. Burlutsky, None; C. Chan, None; S.K. Iyengar, None; J. Tuo, None; C. Xing, None; P. Mitchell, None.
  • Footnotes
    Support Australian NHMRC grants 974159 & 211069 to Smith and Mitchell, NEI grant R01EY 015810 to Iyengar
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 2883. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Complement Factor H, LOC387715 and Age-Related Macular Degeneration: Population-Based Case Control Study
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      W. T. Smith, J. J. Wang, G. Burlutsky, C.-C. Chan, S. K. Iyengar, J. Tuo, C. Xing, P. Mitchell, Blue Mountains Eye Study; Complement Factor H, LOC387715 and Age-Related Macular Degeneration: Population-Based Case Control Study. Invest. Ophthalmol. Vis. Sci. 2007;48(13):2883.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose:: Clinically based case-control studies have reported independent contributions from the complement factor H (CFH) and LOC387715 genes to the risk of age-related macular degeneration (AMD). We aimed to confirm this finding in a population-based case-control study.

Methods:: Cases and controls drawn from the Blue Mountains Eye Study population included 789 subjects (261 cases; 211 early and 50 late, and 528 controls matched for age, gender and smoking). For families with multiple members, only the youngest member of each family was analysed. Subjects were genotyped for the CFH 1061170 locus using Taqman assays and for the LOC387715 (rs#10490924) using PCR-RFLP and Taqman assays. AMD was graded using the Wisconsin ARM photographic grading system. Effects of the 2 gene loci on AMD risk were assessed using logistic regression models that adjusted for age, sex and smoking. Additive and dominant models for the gene risk alleles were used.

Results:: The CFH CC genotype (risk) was found in 15.1% of the sample, CT in 49.4% and TT genotype in 35.5%. The LOC387715 TT genotype (risk) was found in 3.5%, GT in 35.5% and GG in 61.0%. Only two subjects (0.3%) were homozygous for risk at both CFH (CC) and LOC387715 (TT) and were both late AMD cases. Compared to the CFH TT genotype, a gradient pattern of increasing risk for any (early or late) AMD was evident (odds ratio, OR 1.6, 95% confidence intervals, CI 1.1-2.3 for CT and OR 3.9, CI 2.5-6.2 for CC). Compared to LOC387715 GG genotype, corresponding risks for any AMD showed a similar pattern (OR 1.9, CI 1.4-2.7 for GT and OR 2.6, CI 1.2-5.6 for TT). Using dominant models to assess joint effects of both gene loci, persons with any risk alleles in both CFH (CC or CT) and LOC387715 (GT or TT) had similar risks for any or late AMD as those with the homozygous CFH CC risk alleles (any AMD: OR 3.6, CI 2.3-5.8 vs OR 3.9 for CFH CC; late AMD: OR 7.7, CI 2.5-23.3 vs OR 11.0, CI 4.2-28.8 for CFH CC).

Conclusions:: Our data confirm independent effects from the CFH and the LOC387715 risk alleles on the risk of AMD, but do not show joint effects or interaction of these two gene loci on AMD risk using dominant models.

Keywords: age-related macular degeneration • genetics • clinical (human) or epidemiologic studies: risk factor assessment 
© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept